收稿日期: 2024-12-28
网络出版日期: 2025-04-23
基金资助
安徽省临床医学研究转化专项(202304295107020067);宿州市卫生健康科研项目(SZWJ2022a037)
Phenotypic characteristics of early lymphocyte subsets and bronchoscopy findings in children with severe Mycoplasma pneumoniae pneumonia
Received date: 2024-12-28
Online published: 2025-04-23
目的 探讨淋巴细胞亚群绝对数对重症肺炎支原体肺炎(severe mycoplasma pneumonia,SMPP)患儿早期预警的价值及支气管镜检查特点,从而为SMPP的早期诊断提供有价值的参考。 方法 本研究纳入了102例肺炎支原体肺炎(mycoplasma pneumoniae pneumonia, MPP)患儿,其中普通MPP(54例)和SMPP患儿(48例),收集并比较两组患儿淋巴细胞亚群、临床特点及实验室指标。并进一步将患儿分为黏液栓痰组和非黏液栓痰组,比较其淋巴细胞亚群特征。 结果 淋巴细胞亚群CD3+CD19 - T、CD4+T、CD3 - CD19+B、CD3 - /CD16+CD56+ NK细胞绝对数水平两组比较差异均有统计学意义(P < 0.05)。淋巴细胞亚群CD3+、CD4+、CD19+、CD56+绝对计数与铁蛋白、LDH、CRP、D-D均呈负相关(P < 0.05)。多因素logistic回归模型分析发现CD3+CD19 - T、CD4+T、CD3 - CD19+B、CD3 - /CD16+ CD56+ NK绝对计数是SMPP的独立危险因素。ROC曲线分析显示,CD3+CD19 - T、CD4+T、CD3 - CD19+B、CD3 - /CD16+ CD56+ NK细胞绝对计数鉴别诊断SMPP和普通MPP的曲线下面积分别为0.711、0.887、0.856、0.860,其敏感度分别为47.4%、80.8%、82.1%、92.3%,特异度分别为89.7%、87.2%、75%、70.5%。4种淋巴细胞亚群的组合ROC曲线面积为0.983,敏感度为97.4%,特异度为92.3%。SMPP组行支气管镜比例、镜下黏液栓痰高于普通MPP组(P < 0.05)。黏液栓痰组CD3?CD19?T细胞及CD4?T细胞绝对数显著低于非黏液栓痰组,且CD8?T细胞百分比升高、CD4?/CD8?比值降低(P < 0.05)。 结论 外周血CD3+CD19 - T、CD4+T、CD3 - CD19+B、CD3 - /CD16+ CD56+ NK细胞绝对数预测SMPP具有较高的敏感性以及特异性,可作为SMPP的潜在预测指标。SMPP镜下发生黏液栓比例高,需积极行支气管镜治疗;T细胞亚群失衡与支气管镜下黏液栓形成显著相关。
于跑 , 朱峰 , 葛争 , 周碧 , 张立霞 . 重症肺炎支原体肺炎患儿早期淋巴细胞亚群表型特征及支气管镜检查表现[J]. 实用医学杂志, 2025 , 41(7) : 1062 -1069 . DOI: 10.3969/j.issn.1006-5725.2025.07.020
Objective To investigate the value of the absolute number of lymphocyte subpopulations as an early warning indicator for children with SMPP(severe mycoplasma pneumonia, SMPP) and to analyze the characteristics observed via bronchoscopy, thereby providing a valuable reference for the early diagnosis of SMPP. Methods This study included 102 children with Mycoplasma pneumoniae pneumonia (MPP), comprising 54 cases of common MPP and 48 cases of SMPP. The lymphocyte subpopulations, clinical characteristics, and laboratory indicators were analyzed. Results There were statistically significant differences between the two groups in the absolute number levels of lymphocyte subpopulations CD3+CD19-T, CD4+T, CD3-CD19+B, CD3-/CD16+CD56+NK cells (P < 0.05). The absolute numbers of CD3+CD19-T, CD4+T, CD3-CD19+B, and CD3-/CD16+CD56+NK cells showed negative correlations with serum ferritin, LDH, CRP, and D?D, respectively (P < 0.05). Multifactorial logistic regression analysis identified the absolute numbers of CD3+CD19-T, CD4+T, CD3-CD19+B, and CD3-/CD16+CD56+NK cells as independent risk factors for severe Mycoplasma pneumoniae pneumonia (SMPP). ROC analysis demonstrated that the areas under the curve for diagnosing SMPP based on the absolute numbers of CD3+CD19-T, CD4+T, CD3-CD19+B, and CD3-/CD16+CD56+NK cells were 0.711, 0.887, 0.856, and 0.860, respectively, with sensitivities of 47.4%, 80.8%, 82.1%, and 92.3%, and specificities of 89.7%, 87.2%, 75%, and 70.5%, respectively. The combined ROC curve of the four lymphocyte subsets had an area of 0.983, with a sensitivity of 97.4% and specificity of 92.3%. The proportions of bronchoscopy findings and microscopic examination of mucus plugs in the SMPP group were significantly higher than those in the ordinary MPP group (P < 0.05). In the mucoid plug subgroup, the absolute numbers of CD3?CD19?T cells and CD4?T cells were significantly lower compared to the non?mucoid plug subgroup, while the percentage of CD8?T cells increased and the CD4?/CD8? ratio decreased (all P < 0.05). Conclusions The absolute number of CD3+CD19-T, CD4+T, CD3-CD19+B, and CD3-/CD16+CD56+NK cells in peripheral blood serves as a highly sensitive and specific predictor of small airway mucus plugging phenomenon (SMPP) and can thus be utilized as a potential biomarker for SMPP. Microscopic analysis under SMPP conditions reveals a high prevalence of mucus plugs, necessitating proactive bronchoscopic intervention. Furthermore, the significant imbalance in T cell subpopulations is strongly correlated with the formation of mucus plugs observed during bronchoscopy.
| 1 | CHEN D, WU P, LIU D, et al. Clinical role of M. pneumoniae typing antibody detected by chemiluminescent immunoassay in the diagnosis of Mycoplasma pneumoniae pneumonia in children[J]. Int Immunopharmacol,2022,112:109196. doi:10.1016/j.intimp.2022.109196 |
| 2 | 国家卫生健康委员会. 儿童肺炎支原体肺炎诊疗指南(2023年版)[J]. 传染病信息,2023,36(4):291-297. |
| 3 | XIE X Y, ZHOU R Y, DING S A, et al. Emerging trends and concerns in mycoplasma pneumoniae pneumonia among Chinese pediatric population[J]. Pediatr Res,2024,95(6):1388-1390. doi:10.1038/s41390-024-03049-y |
| 4 | MEYER S P, SEILER M, TRUCK J, et al. Diagnosis of mycoplasma pneumoniae pneumonia with measurement of specific antibody-secreting cells[J]. Am J Respir Crit Care Med,2019,200(8):1066-1069. doi:10.1164/rccm.201904-0860le |
| 5 | CHEN Q, HU T, WU L, et al. Clinical features and biomarkers for early prediction of refractory mycoplasma pneumoniae pneumonia in Children[J]. Emerg Med Int,2024,2024:1-7. doi:10.1155/2024/9328177 |
| 6 | YANG M, MENG F, GAO M, et al. Cytokine signatures associate with disease severity in children with mycoplasma pneumoniae pneumonia[J]. Sci Rep,2019,9(1):17853. doi:10.1038/s41598-019-54313-9 |
| 7 | ZHAO J, LI Y, ZHANG W. The clinical significance of IL-6 s and IL-27 s in Bronchoalveolar lavage fluids from children with mycoplasma pneumoniae pneumonia[J]. BMC Infect Dis,2020,20(1):331. doi:10.1186/s12879-020-05017-3 |
| 8 | ZHANG Z, DOU H, TU P, et al. Serum cytokine profiling reveals different immune response patterns during general and severe Mycoplasma pneumoniae pneumonia[J]. Front Immunol,2022,13:1088725. doi:10.3389/fimmu.2022.1088725 |
| 9 | ZHOU L, LI Y, XU Z, et al. Increased Total Serum Immunoglobulin E is likely to cause complications of mycoplasma pneumoniae Pneumonia in Children[J]. Front Cell Infect Microbiol,2021,11:783635. doi:10.3389/fcimb.2021.783635 |
| 10 | BIAN C, LI S, HUO S, et al. Association of atopy with disease severity in children with mycoplasma pneumoniae pneumonia[J].Front Pediatr,2023,11:1281479. doi:10.3389/fped.2023.1281479 |
| 11 | MA L, YAN J, SONG W, et al. Early peripheral blood lymphocyte subsets and cytokines in predicting the severity of influenza B virus pneumonia in children[J]. Front Cell Infect Microbiol,2023,13:1173362. doi:10.3389/fcimb.2023.1173362 |
| 12 | IANNETTA M, BUCCISANO F, FRABONI D, et al. Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: A single center study[J]. Sci Rep,2021,11(1):12762. doi:10.1038/s41598-021-90983-0 |
| 13 | WIK J A, CHOWDHURY A, KOLAN S, et al. Endogenous glutamine is rate-limiting for anti-CD3 and anti-CD28 induced CD4+ T-cell proliferation and glycolytic activity under hypoxia and normoxia[J]. Biochem J,2022,479(11):1221-1235. doi:10.1042/bcj20220144 |
| 14 | BASU D, BASU S, REDDY M, et al. Clinical and laboratory profile of anti-M[J]. Immunohematology,2019,33(4):165-169. |
| 15 | 甄乾娜, 张磊, 王兴斌. 外周血T淋巴细胞亚群和细胞因子在儿童肺炎支原体肺炎诊断中的意义[J]. 检验医学与临床,2017,14(8):1060-1062. |
| 16 | ANDREWS L P, VIGNALI K M, SZYMCZAK-WORKMAN A L, et al. A Cre-driven allele-conditioning line to interrogate CD4(+) conventional T cells[J]. Immunity,2021,54(10):2209-2217. doi:10.1016/j.immuni.2021.08.029 |
| 17 | LEE W J, HUANG E Y, TSAI C M, et al. Role of serum mycoplasma pneumoniae IgA, IgM, and IgG in the diagnosis of mycoplasma pneumoniae-Related pneumonia in school-Age Children and adolescents[J]. Clin Vaccine Immunol,2017,24(1):e00471-16. doi:10.1128/cvi.00471-16 |
| 18 | ZHANG X, SUN R, JIA W, et al. Clinical characteristics of lung consolidation with mycoplasma pneumoniae pneumonia and risk factors for mycoplasma pneumoniae necrotizing pneumonia in Children[J]. Infect Dis Ther,2024,13(2):329-343. doi:10.1007/s40121-023-00914-x |
| 19 | WOOLARD M D, HUDIG D, TABOR L, et al. NK cells in gamma-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp[J]. Infect Immun,2005,73(10):6742-6751. doi:10.1128/iai.73.10.6742-6751.2005 |
| 20 | GAO M, WANG K, YANG M, et al. Transcriptome analysis of bronchoalveolar lavage fluid from Children with mycoplasma pneumoniae pneumonia reveals natural killer and T Cell-Proliferation Responses[J]. Front Immunol,2018,9:1403. doi:10.3389/fimmu.2018.01403 |
| 21 | YANG S, LU S, GUO Y, et al. A comparative study of general and severe mycoplasma pneumoniae pneumonia in children[J].BMC Infect Dis,2024,24(1):449. doi:10.1186/s12879-024-09340-x |
| 22 | 李娜, 穆亚平, 陈静, 等. 淋巴细胞亚群绝对计数对儿童难治性肺炎支原体肺炎的早期预测作用[J]. 中国当代儿科杂志,2019,21(6):511-516. |
| 23 | HUANG X, LI D, LIU F, et al. Clinical significance of D-dimer levels in refractory mycoplasma pneumoniae pneumonia[J]. BMC Infect Dis,2021,21(1):14. doi:10.1186/s12879-020-05700-5 |
| 24 | KAWAMATA R, YOKOYAMA K, SATO M, et al. Utility of serum ferritin and lactate dehydrogenase as surrogate markers for steroid therapy for mycoplasma pneumoniae pneumonia[J]. J Infect Chemother,2015,21(11):783-789. doi:10.1016/j.jiac.2015.07.009 |
| 25 | CHANG Q, CHEN H, WU N, et al. Prediction model for severe mycoplasma pneumoniae pneumonia in pediatric patients by admission laboratory indicators[J]. J Trop Pediatr,2022,68(4):fmac059. doi:10.1093/tropej/fmac059 |
| 26 | LI L, GUO R, ZOU Y, et al. Construction and Validation of a nomogram model to predict the severity of mycoplasma pneumoniae Pneumonia in Children[J]. J Inflamm Res,2024,17:1183-1191. doi:10.2147/jir.s447569 |
| 27 | ZHANG J, WANG T, LI R, et al. Prediction of risk factors of bronchial mucus plugs in children with mycoplasma pneumoniae pneumonia[J]. BMC Infect Dis,2021,21(1):67. doi:10.1186/s12879-021-05765-w |
| 28 | 彭力,钟礼立,林琳, 等. 黏蛋白MUC5AC在肺炎支原体肺炎患儿气道中的表达及临床意义[J]. 实用医学杂志,2023,39(20):2618-2622. |
/
| 〈 |
|
〉 |